Skip to main content

Table 2 Maternal poliovirus type-specific antibody levels of the study participants

From: The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines

Group

N

Type

Positive participants

Positive rate (%)

GMT

Participants with different titers (1:)

< 8

8 ~ < 32

≥32

1

109

I

82

75.23

17.57

27

47

35

II

49

44.95

8.39

60

33

16

III

29

26.61

6.13

80

20

9

2

125

I

98

78.40

18.44

27

50

48

II

43

34.40

6.73

82

30

13

III

23

18.40

5.33

102

19

4

3

127

I

90

70.87

17.99

37

39

51

II

46

36.22

6.69

81

35

11

III

21

16.54

5.59

106

14

7

4

124

I

96

77.42

21.21

28

40

56

II

47

37.90

6.44

77

42

5

III

33

26.61

6.41

91

23

10

5

124

I

95

76.61

19.15

29

45

50

II

46

37.10

6.92

78

36

10

III

31

25.00

5.79

93

25

6

  1. Group 1: low-dose Sabin IPV group. Group 2: medium-dose Sabin IPV group. Group 3: high-dose Sabin IPV group. Group 4: control Sabin IPV group. Group 5: control Salk IPV group